Autoantibody targets in vaccine-associated narcolepsy

References

• Kornum, B. R., J. Faraco, E. Mignot. 2011. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr. Opin. Neurobiol. 21:897–903
   PubMed Web of Science ®Google Scholar
• Kumar, S., H. Sagili. 2014. Etiopathogenesis and neurobiology of narcolepsy: a review. J. Clin. Diagn. Res. 8:190–195
   PubMedGoogle Scholar
• Mignot, E., R. Hayduk, J. Black, et al. 1997. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep. 20:1012–1020
   PubMed Web of Science ®Google Scholar
• Faraco, J., L. Lin, B. R. Kornum, et al. 2013. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Gen. 9:e1003270
   PubMed Web of Science ®Google Scholar
• Hallmayer, J., J. Faraco, L. Lin, et al. 2009. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat. Gen. 41:708–711
   PubMed Web of Science ®Google Scholar
• Kornum, B. R., M. Kawashima, J. Faraco, et al. 2011. Common variants in P2RY11 are associated with narcolepsy. Nat. Gen. 43:66–71
   PubMed Web of Science ®Google Scholar
• Nohynek, H., J. Jokinen, M. Partinen, et al. 2012. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One. 7:e33536
   PubMed Web of Science ®Google Scholar
• O'Flanagan, D., A. S. Barret, M. Foley, et al. 2014. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009–December 2010. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 19:15–25
   PubMedGoogle Scholar
• Widgren, K., M. Magnusson, P. Hagstam, et al. 2013. Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 18:20447
   PubMedGoogle Scholar
• Wijnans, L., C. Lecomte, C. de Vries, et al. 2013. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine. 31:1246–1254
   PubMed Web of Science ®Google Scholar
• Persson, I., F. Granath, J. Askling, et al. 2014. Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J. Int. Med. 275:172–190
   PubMed Web of Science ®Google Scholar
• The Swedish Medical Products Agency (Läkemedelsverket) - The MPA investigates reports of narcolepsy in patients vaccinated with Pandemrix. Available at: https://lakemedelsverket.se/english/All-news/NYHETER-2010/The-MPA-investigates-reports-of-narcolepsy-in-patients-vaccinated-with-Pandemrix/; 2010
   Google Scholar
• Bardage, C., I. Persson, A. Ortqvist, et al. 2011. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BMJ. 343:d5956
   PubMed Web of Science ®Google Scholar
• Heier, M. S., K. M. Gautvik, E. Wannag, et al. 2013. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med. 14:867–871
   PubMed Web of Science ®Google Scholar
• Dauvilliers, Y., I. Arnulf, M. Lecendreux, et al. 2013. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain. 136:2486–2496
   PubMed Web of Science ®Google Scholar
• Szakacs, A., N. Darin, T. Hallbook. 2013. Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology. 80:1315–1321
   PubMed Web of Science ®Google Scholar
• Miller, E., N. Andrews, L. Stellitano, et al. 2013. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ. 346:f794
   PubMed Web of Science ®Google Scholar
• Partinen, M., O. Saarenpaa-Heikkila, I. Ilveskoski, et al. 2012. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One. 7:e33723
   PubMed Web of Science ®Google Scholar
• Blank, M., O. Barzilai, Y. Shoenfeld. Molecular mimicry and auto-immunity. 2007. Clin. Rev. Allergy Immunol. 32:111–118
   PubMed Web of Science ®Google Scholar
• Mahlios, J., A. K. De la Herran-Arita, E. Mignot. 2013. The autoimmune basis of narcolepsy. Curr. Opin. Neurobiol. 23:767–773
   PubMed Web of Science ®Google Scholar
• Ahmed, S. S., W. Volkmuth, J. Duca, et al. 2015. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci. Transl. Med. 7:294ra105
   PubMed Web of Science ®Google Scholar
• Cvetkovic-Lopes, V., L. Bayer, S. Dorsaz, et al. 2010. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J. Clin. Invest. 120:713–719
   PubMed Web of Science ®Google Scholar
• Lind, A., A. Ramelius, T. Olsson, et al. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009–2010. J. Autoimmun. 2014:1–8
   Google Scholar
• Katzav, A., M. T. Arango, S. Kivity, et al. 2013. Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice. J. Autoimmun. 45:24–30
   PubMed Web of Science ®Google Scholar
• Bergman, P., C. Adori, S. Vas, et al. 2014. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc. Natl. Acad. Sci. USA. 111:E3735–E3744
   PubMed Web of Science ®Google Scholar
• Smith, A. J., M. W. Jackson, P. Neufing, et al. 2004. A functional autoantibody in narcolepsy. Lancet. 364:2122–2124
   PubMed Web of Science ®Google Scholar
• Ayoglu, B., A. Haggmark, M. Khademi, et al. 2013. Autoantibody profiling in multiple sclerosis using arrays of human protein fragments. Mol. Cell. Proteomics. 12:2657–2672
   PubMed Web of Science ®Google Scholar
• Feltelius, N., I. Persson, Ahlqvist-Rastad J., et al. 2015. A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009–2010 Pandemrix vaccination programme in Sweden. J. Int. Med. 278:335–353
   PubMed Web of Science ®Google Scholar
• Bohan, A., J. B. Peter. 1975. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292:344–347
   PubMed Web of Science ®Google Scholar
• Griggs, R. C., V. Askanas, S. DiMauro, et al. 1995. Inclusion body myositis and myopathies. Ann. Neurol. 38:705–713
   PubMed Web of Science ®Google Scholar
• Agaton, C., R. Falk, I. Hoiden Guthenberg, et al. 2004. Selective enrichment of monospecific polyclonal antibodies for antibody-based proteomics efforts. J. Chromatogr. A. 1043:33–40
   PubMed Web of Science ®Google Scholar
• Berglund, L., E. Bjorling, K. Jonasson, et al. 2008. A whole-genome bioinformatics approach to selection of antigens for systematic antibody generation. Proteomics. 8:2832–2839
   PubMed Web of Science ®Google Scholar
• Häggmark, A., C. Hamsten, E. Wiklundh, et al. 2015. Proteomic profiling reveals autoimmune targets in sarcoidosis. Am. J. Respir. Crit. Care. Med. 191:574–583
   PubMed Web of Science ®Google Scholar
• Forsstrom, B., B. B. Axnas, K. P. Stengele, et al. 2014. Proteome-wide epitope mapping of antibodies using ultra-dense peptide arrays. Mol. Cell. Proteomics. 13:1585–1597
   PubMed Web of Science ®Google Scholar
• Henjes, F., L. Lourido, C. Ruiz-Romero, et al. 2014. Analysis of autoantibody profiles in osteoarthritis using comprehensive protein array concepts. J. Proteome Res. 13:5218–5229
   PubMed Web of Science ®Google Scholar
• Altschul, S. F., T. L. Madden, A. A. Schaffer, et al. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389–3402
   PubMed Web of Science ®Google Scholar
• Kringelum, J. V., M. Nielsen, S. B. Padkjaer, O. Lund. 2013. Structural analysis of B-cell epitopes in antibody: protein complexes. Mol. Immunol. 53:24–34
   PubMed Web of Science ®Google Scholar
• Cloutier, P., M. Lavallee-Adam, D. Faubert, et al. 2013. A newly uncovered group of distantly related lysine methyltransferases preferentially interact with molecular chaperones to regulate their activity. PLoS Gen. 9:e1003210
   PubMedGoogle Scholar
• Despras, E., L. Miccoli, C. Creminon, et al. 2003. Depletion of KIN17, a human DNA replication protein, increases the radiosensitivity of RKO cells. Radiat. Res. 159:748–758
   PubMed Web of Science ®Google Scholar
• Borowiec, A., K. Lechward, K. Tkacz-Stachowska, A. C. Skladanowski. 2006. Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5′-nucleotidases. Acta Biochim. Pol. 53:269–278
   PubMed Web of Science ®Google Scholar
• Larman, H. B., M. Salajegheh, R. Nazareno, et al. 2013. Cytosolic 5′-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. Ann. Neurol. 73:408–418
   PubMed Web of Science ®Google Scholar
• Gass, N., H. M. Ollila, S. Utge, et al. 2010. Contribution of adenosine related genes to the risk of depression with disturbed sleep. J. Affect. Disord. 126:134–139
   PubMed Web of Science ®Google Scholar
• Thakkar, M. M., S. C. Engemann, K. M. Walsh, P. K. Sahota. 2008. Adenosine and the homeostatic control of sleep: effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness. Neuroscience. 153:875–880
   PubMed Web of Science ®Google Scholar
• Schwartz, M., I. Shaked, J. Fisher, et al. 2003. Protective autoimmunity against the enemy within: fighting glutamate toxicity. Trends Neurosci. 26:297–302
   PubMed Web of Science ®Google Scholar
• Piani, D., K. Frei, K. Q. Do, et al. 1991. Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133:159–162
   PubMed Web of Science ®Google Scholar
• Alexopoulos, H., E. I. Kampylafka, I. Chatzi, et al. 2013. Reactivity to AQP4 epitopes in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 260:117–120
   PubMed Web of Science ®Google Scholar
• Belogurov, A. A. Jr., I. N. Kurkova, A. Friboulet, et al. 2008. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. J. Immunol. 180:1258–1267
   PubMed Web of Science ®Google Scholar
• Tanaka, S., Y. Honda, Y. Inoue, M. Honda. 2006. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. Sleep. 29:633–638
   PubMed Web of Science ®Google Scholar
• Haggmark, A., J. M. Schwenk, P. Nilsson. 2016. Neuroproteomic profiling of human body fluids. Proteomics Clin. Appl. 10:485–502
   PubMed Web of Science ®Google Scholar